Evidence map›Paper›PMID 21421907›Full record

ArticleAmerican journal of respiratory cell and molecular biology2011

Inducible costimulator controls migration of T cells to the lungs via down-regulation of CCR7 and CD62L.

Tamson V Moore, Bryan S Clay, Judy L Cannon, Alexander Histed, Rebecca A Shilling, Anne I Sperling

Open access · greenAbstract read
In one paragraph

Article in American journal of respiratory cell and molecular biology, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 17 citations in OpenAlex.

  1. Metabolic priming of GD2Molecular therapy. Methods & clinical development · 2024
    Article
  2. Article
  3. Article
  4. ICOSFrontiers in immunology · 2020
    Review
  5. Article
  6. Down-Regulation of CD62L Shedding in T Cells by CD39The Journal of investigative dermatology · 2017
    Article
  7. Article
  8. Effector and central memory T helper 2 cells respond differently to peptide immunotherapy.Proceedings of the National Academy of Sciences of the United States of America · 2014
    Article
  9. Review
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Tamson V MooreCommittee on Immunology and Section of Pulmonary and Critical Care, Department of Medicine, University of Chicago, 5841 S. Maryland Ave., Chicago, IL 60637, USA.
Bryan S Clay
Judy L Cannon
Alexander Histed
Rebecca A Shilling
Anne I Sperling
University of Chicago · US

Funding

Regulation and expression of HLA-G in asthmatic airwaysU19AI095230 · NIAID · UNIVERSITY OF CHICAGO · PI WHITE, STEVEN R · 2011 to 2016
$10.5M
Mechanisms of Resolution in Experimental AsthmaR01AI067697 · NIAID · UNIVERSITY OF CHICAGO · PI SPERLING, ANNE I. · 2007 to 2011
$1.9M
ICOS Expression Levels and Th DevelopmentK08AI059105 · NIAID · UNIVERSITY OF CHICAGO · PI SHILLING, REBECCA A. · 2006 to 2010
$576k
NIAID NIH HHS K08 AI059105NIAID NIH HHS R01 AI067697NIAID NIH HHS R01 AI67697NIAID NIH HHS U19 AI095230
6 · The paper itself

Abstract

We and others reported that inducible costimulator-deficient (ICOS(-/-)) mice manifest a defect in Th2-mediated airway inflammation, which was attributed to reduced Th2 differentiation in the absence of ICOS signaling. Interestingly, the number of CD4 T cells present in the airways and lungs after sensitization and challenge is significantly reduced in ICOS(-/-) mice. We now show that this reduction is not attributable simply to a reduced proliferation of ICOS(-/-) cells, because significantly more ICOS(-/-) than wild-type activated CD4 T cells are present in the lymph nodes, suggesting that more ICOS(-/-) CD4 T cells than wild-type CD4 T cells migrated into the lymph nodes. Further investigation revealed that activated ICOS(-/-) CD4 T cells express higher concentrations of the lymph node homing receptors, CCR7 and CD62L, than do wild-type CD4 T cells, leading to a preferential return of ICOS(-/-) cells to the nondraining lymph nodes rather than the lungs. Blocking reentry into the lymph nodes after the initiation of Th2-mediated airway inflammation equalized the levels of CD4 and granulocyte infiltration in the lungs of wild-type and ICOS(-/-) mice. Our results demonstrate that in wild-type CD4 T cells, co-stimulation with ICOS promotes the down-regulation of CCR7 and CD62L after activation, leading to a reduced return of activated CD4 T cells to the lymph nodes and a more efficient entry into the lungs.

Indexed as

Chemotaxis, LeukocyteAdoptive TransferAnimalsAntigens, Differentiation, T-LymphocyteAntigens, HelminthBronchoalveolar Lavage FluidCD4-Positive T-LymphocytesCell ProliferationCells, CulturedDisease Models, AnimalDown-RegulationInducible T-Cell Co-Stimulator ProteinL-SelectinLungLymph NodesLymphocyte ActivationAntigens, Differentiation, T-LymphocyteAntigens, HelminthCcr7 protein, mouseIcos protein, mouseInducible T-Cell Co-Stimulator ProteinL-SelectinReceptors, CCR7

Identifiers

PMID21421907
PMCPMC3208611
OpenAlexW1968872461

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.